⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 29, 2012MedChemComm

Approaches to discover non-ATP site kinase inhibitors

Lori K. Gavrin Eddine Saiah

View at Publisher

Ask AI

Bookmark

Share

Abstract

This review will highlight the most commonly used methods to discover small molecule Type III/IV kinase inhibitors.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gavrin et al. (2012) studied this question.

synapsesocial.com/papers/69fd25c57467cb4cde27064c https://doi.org/10.1039/c2md20180a

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Protein Kinase Complement of the Human GenomeOriginal Research · 2002 · 8,098 citations
2Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseOriginal Research · 2000 · 1,781 citations
3Tinkering Outside the Kinase ATP Box: Allosteric (Type IV) and Bivalent (Type V) Inhibitors of Protein KinasesOriginal Research · 2010 · 65 citations
4Tethering Small Molecules to a Phage Display Library: Discovery of a Selective Bivalent Inhibitor of Protein Kinase AOriginal Research · 2007 · 65 citations
5Development of Selective Bisubstrate‐Based Inhibitors Against Protein Kinase C (PKC) Isozymes By Using Dynamic Peptide MicroarraysOriginal Research · 2009 · 33 citations

More related papers

Structural Bioinformatics-Based Design of Selective, Irreversible Kinase Inhibitors2005
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib2005
Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase2004

More from MedChemComm

Synthesis, conformational preferences, and biological activity of conformational analogues of the microtubule-stabilizing agents, (−)-zampanolide and (−)-dactylolideTue,
Selective in vitro anti-cancer activity of non-alkylating minor groove bindersTue,